Portal de Periódicos da CAPES

Attenuation of Tolerance to Opioid‐Induced Antinociception by Idazoxan and Other I 2 ‐Ligands a

1999; Wiley; Volume: 881; Issue: 1 Linguagem: Inglês

10.1111/j.1749-6632.1999.tb09380.x

1749-6632

M Assumpció Boronat, Gabriel Olmos, Jesús A. García‐Sevilla,

Neuroscience and Neuropharmacology Research

Annals of the New York Academy of SciencesVolume 881, Issue 1 p. 359-363 Attenuation of Tolerance to Opioid-Induced Antinociception by Idazoxan and Other I2-Ligands† M. ASSUMPCIÓ BORONAT, M. ASSUMPCIÓ BORONAT Laboratory of Neuropharmacology, Associate Unit of the Institute of Neurobiology Ramón y Cajal/CSIC, Department of Biology, University of the Balearic Islands Cra. Valldemossa km 7.5, E-07071 Palma de Mallorca, SpainSearch for more papers by this authorGABRIEL OLMOS, GABRIEL OLMOS Laboratory of Neuropharmacology, Associate Unit of the Institute of Neurobiology Ramón y Cajal/CSIC, Department of Biology, University of the Balearic Islands Cra. Valldemossa km 7.5, E-07071 Palma de Mallorca, SpainSearch for more papers by this authorJESÚS A. GARCÍA-SEVILLA, JESÚS A. GARCÍA-SEVILLA Laboratory of Neuropharmacology, Associate Unit of the Institute of Neurobiology Ramón y Cajal/CSIC, Department of Biology, University of the Balearic Islands Cra. Valldemossa km 7.5, E-07071 Palma de Mallorca, SpainSearch for more papers by this author M. ASSUMPCIÓ BORONAT, M. ASSUMPCIÓ BORONAT Laboratory of Neuropharmacology, Associate Unit of the Institute of Neurobiology Ramón y Cajal/CSIC, Department of Biology, University of the Balearic Islands Cra. Valldemossa km 7.5, E-07071 Palma de Mallorca, SpainSearch for more papers by this authorGABRIEL OLMOS, GABRIEL OLMOS Laboratory of Neuropharmacology, Associate Unit of the Institute of Neurobiology Ramón y Cajal/CSIC, Department of Biology, University of the Balearic Islands Cra. Valldemossa km 7.5, E-07071 Palma de Mallorca, SpainSearch for more papers by this authorJESÚS A. GARCÍA-SEVILLA, JESÚS A. GARCÍA-SEVILLA Laboratory of Neuropharmacology, Associate Unit of the Institute of Neurobiology Ramón y Cajal/CSIC, Department of Biology, University of the Balearic Islands Cra. Valldemossa km 7.5, E-07071 Palma de Mallorca, SpainSearch for more papers by this author First published: 06 February 2006 https://doi.org/10.1111/j.1749-6632.1999.tb09380.xCitations: 8Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1 Self, D. W., &E. J. Nestler. 1995. Annu. Rev. Neurosci. 18: 463–495. 10.1146/annurev.ne.18.030195.002335 PubMedWeb of Science®Google Scholar 2 Herman, B., F. Vocci & P. Bridge. 1995. Neuropsychopharmacology 13: 269–293. 10.1016/0893-133X(95)00140-9 CASPubMedWeb of Science®Google Scholar 3 Kolesnikov, Y., S. Jain & G. W. Pasternak. 1996. Eur. J. Pharmacol. 296: 17–22. PubMedWeb of Science®Google Scholar 4 Beitner-Johnson, D., X. Guitart & E. J. Nestler. 1992. J. Neurosci. 12: 2165–2176. PubMedWeb of Science®Google Scholar 5 García-Sevilla, J. A., P. Ventayol, X. Busquets, R. La Harpe, C. Walzer & J. Guimón. 1997. NeuroReport 8: 1561–1565. 10.1097/00001756-199705060-00003 CASPubMedWeb of Science®Google Scholar 6 Nestler, E. J., M. T. Berhow & E. S. Brodkin. 1996. Mol. Psychiat. 1: 190–199. PubMedWeb of Science®Google Scholar 7 Maiese, K., L. Pek, S. B. Berger & D. J. Reis. 1992. J. Cereb. Blood Flow Metab. 12: 53–63. 10.1038/jcbfm.1992.7 CASPubMedWeb of Science®Google Scholar 8 Gilad, G. M., K. Salame, J. M. Rabey & V. H. Gilad. 1996. Life Sci. 58: PL 41–46. Google Scholar 9 D'Amour, F. E. & D. L. Smith. 1941. J. Pharmacol. Exp. Ther. 72: 74–79. Web of Science®Google Scholar 10 Olmos, G., R. Alemany, P. V. Escribá & J. A. García-Sevilla. 1994. Br. J. Pharmacol. 111: 997–1002. 10.1111/j.1476-5381.1994.tb14842.x PubMedWeb of Science®Google Scholar 11 Ozaita, A., G. Olmos, M. A. Boronat, J. M. Lizcano, M. Unzeta & J. A. García-Sevilla. 1997. Br. J. Pharmacol. 121: 901–912. 10.1038/sj.bjp.0701214 PubMedWeb of Science®Google Scholar 12 Miralles, A., G. Olmos, M. Sastre, F. Barturen, I. Martin & J. A. García-Sevilla. 1993. J. Pharmacol. Exp. Ther. 264: 1187–1197. CASPubMedWeb of Science®Google Scholar 13 Brown, C. M., A. C. MacKinnon, W. S. Redfern, P. E. Hicks, A. T. Kilpatrick, C. Small, M. Ramcharan, R. U. Clague, R. D. Clark, C. B. MacFarlane & M. Spedding. 1993. Br. J. Pharmacol. 108: 516–525. 10.1111/j.1476-5381.1993.tb12834.x PubMedWeb of Science®Google Scholar 14 Likungu, J., G. J. Molderings & M. Göthert. 1996. Naunyn-Schmiedeberg's Arch. Pharmacol. 354: 689–692. PubMedWeb of Science®Google Scholar 15 Guerrero Muñoz, F., K. V. Cerreta, M. L. Guerrero & E. L. Way. 1979. J. Pharmacol. Exp. Ther. 209: 132–136. Web of Science®Google Scholar 16 Tesson, F., C. Prip-Buus, A. Lemoine, J.-P. Pegorier & A. Parini. 1991. J. Biol. Chem. 266: 155–160. PubMedWeb of Science®Google Scholar 17 Alemany, R., G. Olmos, P. V. Escribá, A. Menargues, R. Obach & J. A. García-Sevilla. 1995. Eur. J. Pharmacol. 280: 205–210. PubMedWeb of Science®Google Scholar 18 Boronat, M. A., G. Olmos & J. A. García-Sevilla. 1998. Br. J. Pharmacol. 125: 175–185. 10.1038/sj.bjp.0702031 PubMedWeb of Science®Google Scholar Citing Literature Volume881, Issue1IMIDAZOLINE RECEPTORS AND THEIR ENDOGENOUS LIGANDS: CURRENT CONCEPTS AND THERAPEUTIC POTENTIALJune 1999Pages 359-363 ReferencesRelatedInformation